PAK2 Antikörper (C-Term)

Produktnummer ABIN318772

Produktdetails anti-PAK2 Antikörper

Target: PAK2 (P21-Activated Kinase 2 (PAK2))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PAK2 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Spezifität: This antibody recognises p21-activated kinase-2 (PAK2).

Aufreinigung: Purified

Immunogen: 14 amino acid peptide sequence near the carboxy terminus of human PAK2

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Western Blot: 0.5 - 1.0g/mL, detects a band of approximately 58 kDa in Jurkat cell lysates.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: 1.0 mg/mL

Buffer: Phosphate buffered saline containing 0.02 % Sodium Azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handhabung: Avoid repeated freezing and thawing.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Details zu PAK2

Target: PAK2 (P21-Activated Kinase 2 (PAK2))

Andere Bezeichnung: PAK2 (PAK2 Produkte)

Synonyme: PAK65 antikoerper, PAKgamma antikoerper, gamma-PAK antikoerper, 5330420P17Rik antikoerper, A130002K10Rik antikoerper, AI836325 antikoerper, D16Ertd269e antikoerper, PAK-2 antikoerper, mKIAA4182 antikoerper, pak2 antikoerper, cb422 antikoerper, kinase antikoerper, zgc:91798 antikoerper, wu:fb71h01 antikoerper, si:dz198m22.1 antikoerper, pak65 antikoerper, pakgamma antikoerper, PAKI antikoerper, Pak3 antikoerper, CH73-159L23.1 antikoerper, wu:fc52b03 antikoerper, zgc:113857 antikoerper, p21 (RAC1) activated kinase 2 antikoerper, p21 protein (Cdc42/Rac)-activated kinase 2 antikoerper, p21 protein (Cdc42/Rac)-activated kinase 2a antikoerper, p21 protein (Cdc42/Rac)-activated kinase 2 S homeolog antikoerper, p21 protein (Cdc42/Rac)-activated kinase 2b antikoerper, PAK2 antikoerper, Pak2 antikoerper, pak2a antikoerper, pak2.S antikoerper, pak2b antikoerper

Hintergrund: PAK2 is a ubiquitously expressed, 64 kDa, serine/threonine protease found at higher levels in skeletal muscle, ovary, thymus and spleen. p21-activated kinases (PAKs) bind activated Cdc42 and Rac via a Cdc42/Rac interactive binding (CRIB) domain. Group 1 PAK kinases (PAK1, 2 and 3) regulate the activity of an adjacent conserved autoinhibitory domain and are associated with cellular processes, including cytoskeleton rearrangement, apoptosis and MAP kinase signalling. Group 2 PAKs (PAK4, 5, and 6) lack the autoinhibitory domain and are not activated by Cdc42/Rac binding. PAK2 has a cytostatic effect on cells and is activated in response to cellular stresses such hyperosmolarity, serum starvation, contact inhibition and DNA damage from radiation and chemicals. Unlike other PAKs, PAK2 can be activated by proteolytic cleavage to generate a constitutively active fragment, PAK2p34, which induces a cell death response. This induction is thought to be regulated by Rho GTPase-activating protein 10 which inhibits the protein kinase activity of PAK2p34 and causes it to localise to the perinuclear region instead of the nucleus. PAK2 may also play a role in X-linked mental retardation.Synonyms: Gamma-PAK, PAK 2, PAK gamma, PAK-2, PAK65, Serine/threonine-protein kinase PAK 2, p21-activated kinase 2, p58

Gen-ID: 5062

NCBI Accession: NP_002568

UniProt: Q13177

Pathways: MAPK Signalweg, RTK Signalweg, T-Zell Rezeptor Signalweg, Fc-epsilon Rezeptor Signalübertragung, Regulation of Lipid Metabolism by PPARalpha